We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Rapid, Selective, and Sensitive LC-MS/MS Method Determines Antioxidant Level in Blood Plasma.

Read time: Less than a minute

A small team of scientists from China’s Heibei University have developed an LC-MS/MS method for assessing blood plasma concentrations of an antioxidant isolated from paeonies that has been suggested to have therapeutic implications in the treatment of Alzheimer’s Disease.

Benzoylpaeoniflorin (BP) is a potential therapeutic agent against the oxidative stress underlying the neurodegeneration seen in Alzheimer's disease.

In this study, a more rapid, selective, and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed to determine BP in rat plasma, distinguishing it from the similar monoterpene isomer, benzoylalbiflorin (BA).

The method showed a linear response from 1 to 1000 ng/mL (r > 0.9950). The precision of the interday and intraday ranged from 2.03 to 12.48% and the accuracy values ranged from −8.00 to 10.33%.

Most importantly, the method could be run and finished in 4 minutes.

The LC-MS/MS method was validated for specificity, linearity, precision, accuracy, recovery, and stability and was found to be acceptable for bioanalytical application. As a final test, the fully validated method was successfully applied to a pharmacokinetic study in rats following oral administration.

Reference:

Zhou, C. and Wang, X. (2017). Rapid Determination of Isomeric Benzoylpaeoniflorin and Benzoylalbiflorin in Rat Plasma by LC-MS/MS Method. International Journal of Analytical Chemistry, 2017, pp.1-9.


Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.